These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 19126297)

  • 41. Linagliptin: a novel methylxanthin based approved dipeptidyl peptidase-4 inhibitor.
    Agrawal R; Jain P; Dikshit SN
    Curr Drug Targets; 2012 Jun; 13(7):970-83. PubMed ID: 22420306
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 3,5-Dihydro-imidazo[4,5-d]pyridazin-4-ones: a class of potent DPP-4 inhibitors.
    Eckhardt M; Hauel N; Himmelsbach F; Langkopf E; Nar H; Mark M; Tadayyon M; Thomas L; Guth B; Lotz R
    Bioorg Med Chem Lett; 2008 Jun; 18(11):3158-62. PubMed ID: 18485703
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The dipeptidyl peptidase-4 inhibitor linagliptin exhibits time- and dose-dependent localization in kidney, liver, and intestine after intravenous dosing: results from high resolution autoradiography in rats.
    Greischel A; Binder R; Baierl J
    Drug Metab Dispos; 2010 Sep; 38(9):1443-8. PubMed ID: 20538719
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Population pharmacokinetic/pharmacodynamic analysis of the DPP-4 inhibitor linagliptin in Japanese patients with type 2 diabetes mellitus.
    Tadayasu Y; Sarashina A; Tsuda Y; Tatami S; Friedrich C; Retlich S; Staab A; Takano M
    J Pharm Pharm Sci; 2013; 16(5):708-21. PubMed ID: 24393553
    [TBL] [Abstract][Full Text] [Related]  

  • 45. DPP-4 inhibitors in the treatment of type 2 diabetes.
    Duez H; Cariou B; Staels B
    Biochem Pharmacol; 2012 Apr; 83(7):823-32. PubMed ID: 22172989
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Design, synthesis, biological evaluation, and docking studies of (s)-phenylalanine derivatives with a 2-cyanopyrrolidine moiety as potent dipeptidyl peptidase 4 inhibitors.
    Liu Y; Wu Y; Wu H; Tang L; Wu P; Liu T; Hu Y
    Chem Biol Drug Des; 2013 Aug; 82(2):140-6. PubMed ID: 23530834
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dipeptidyl peptidase IV inhibitory peptides generated in Spanish dry-cured ham.
    Gallego M; Aristoy MC; Toldrá F
    Meat Sci; 2014 Feb; 96(2 Pt A):757-61. PubMed ID: 24200567
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of the pharmacokinetics, food effect, pharmacodynamics, and tolerability of DA-1229, a dipeptidyl peptidase IV inhibitor, in healthy volunteers: first-in-human study.
    Kim TE; Lim KS; Park MK; Yoon SH; Cho JY; Shin SG; Jang IJ; Yu KS
    Clin Ther; 2012 Sep; 34(9):1986-98. PubMed ID: 22943970
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis and biological evaluation of all eight stereoisomers of DPP-IV inhibitor saxagliptin.
    Dong J; Gong Y; Liu J; Chen X; Wen X; Sun H
    Bioorg Med Chem; 2014 Feb; 22(4):1383-93. PubMed ID: 24457090
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Glucose-independent improvement of vascular dysfunction in experimental sepsis by dipeptidyl-peptidase 4 inhibition.
    Kröller-Schön S; Knorr M; Hausding M; Oelze M; Schuff A; Schell R; Sudowe S; Scholz A; Daub S; Karbach S; Kossmann S; Gori T; Wenzel P; Schulz E; Grabbe S; Klein T; Münzel T; Daiber A
    Cardiovasc Res; 2012 Oct; 96(1):140-9. PubMed ID: 22843705
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis and biological evaluation of azobicyclo[3.3.0] octane derivatives as dipeptidyl peptidase 4 inhibitors for the treatment of type 2 diabetes.
    Cho TP; Long YF; Gang LZ; Yang W; Jun LH; Yuan SG; Hong FJ; Lin W; Liang GD; Lei Z; Jing LJ; Shen GA; Hong SG; Dan W; Ying F; Ke YP; Ying L; Jun F; Tai MX
    Bioorg Med Chem Lett; 2010 Jun; 20(12):3565-8. PubMed ID: 20488702
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The concentration-dependent binding of linagliptin (BI 1356) and its implication on efficacy and safety.
    Wright S; Singh RP; Retlich S; Graefe-Mody U; Derendorf H
    Int J Clin Pharmacol Ther; 2012 May; 50(5):323-30. PubMed ID: 22541836
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of dipeptidyl peptidase IV inhibitors: virtual screening, synthesis and biological evaluation.
    Xing J; Li Q; Zhang S; Liu H; Zhao L; Cheng H; Zhang Y; Zhou J; Zhang H
    Chem Biol Drug Des; 2014 Sep; 84(3):364-77. PubMed ID: 24674599
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Linagliptin: a new DPP-4 inhibitor for the treatment of type 2 diabetes mellitus.
    Toth PP
    Postgrad Med; 2011 Jul; 123(4):46-53. PubMed ID: 21680988
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of 3-aminomethyl-1,2-dihydro-4-phenyl-1-isoquinolones: a new class of potent, selective, and orally active non-peptide dipeptidyl peptidase IV inhibitors that form a unique interaction with Lys554.
    Banno Y; Miyamoto Y; Sasaki M; Oi S; Asakawa T; Kataoka O; Takeuchi K; Suzuki N; Ikedo K; Kosaka T; Tsubotani S; Tani A; Funami M; Tawada M; Yamamoto Y; Aertgeerts K; Yano J; Maezaki H
    Bioorg Med Chem; 2011 Aug; 19(16):4953-70. PubMed ID: 21764322
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthesis, structure-activity relationship, and pharmacophore modeling studies of pyrazole-3-carbohydrazone derivatives as dipeptidyl peptidase IV inhibitors.
    Wu D; Jin F; Lu W; Zhu J; Li C; Wang W; Tang Y; Jiang H; Huang J; Liu G; Li J
    Chem Biol Drug Des; 2012 Jun; 79(6):897-906. PubMed ID: 22381062
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differential chemistry (structure), mechanism of action, and pharmacology of GLP-1 receptor agonists and DPP-4 inhibitors.
    Neumiller JJ
    J Am Pharm Assoc (2003); 2009; 49 Suppl 1():S16-29. PubMed ID: 19801361
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of dipeptidyl peptidase IV (DPP-IV) by tryptophan containing dipeptides.
    Nongonierma AB; Fitzgerald RJ
    Food Funct; 2013 Dec; 4(12):1843-9. PubMed ID: 24193022
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of dipeptidyl peptidase IV with sitagliptin (MK0431) prolongs islet graft survival in streptozotocin-induced diabetic mice.
    Kim SJ; Nian C; Doudet DJ; McIntosh CH
    Diabetes; 2008 May; 57(5):1331-9. PubMed ID: 18299314
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis, evaluation and molecular docking of thiazolopyrimidine derivatives as dipeptidyl peptidase IV inhibitors.
    Sharma M; Gupta M; Singh D; Kumar M; Kaur P
    Chem Biol Drug Des; 2012 Dec; 80(6):918-28. PubMed ID: 22943413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.